The “Epicovid 2.0” study shows that the “impacts of the pandemic are great and long-lasting” and that it has “exacerbated ...

Faster post-COVID-19 recovery is observed after infection with the Omicron vs earlier variants, regardless of vaccination status.

Women are at a higher risk of developing long Covid than men although men are more likely to suffer from severe Covid-19 ...

The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.

The Omicron variant of the coronavirus is suspected to be the ... according to a pre-print of a new study completed by the team.

Paxlovid use was associated with lower rates of hospitalization and death, particularly among older adults, a new study finds ...

COVID-19 continues to be a threat to America's health, causing more illness and death than either influenza or respiratory ...

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.

A small study published Monday found that the COVID ... the delta variant and the omicron variant. The participants took Paxlovid from seven-and-a-half days to 30 days. The group included people ...